This was the first time that anti-glycan IgE could definitely be associated with clinically relevant allergic reactions when compared to “classical” cross-reactive carbohydrate determinants (CCDs) that represent less clinically relevant pan-allergens throughout the plant kingdom [11,12]. Here, IGHE is linked to allergic disease.